首页> 外文期刊>The Lancet >Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients.
【24h】

Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients.

机译:DNA疫苗在HIV-1感染患者中诱导的细胞毒性反应。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: DNA vaccination is known to generate immune responses against HIV-1 in animal models. We aimed to assess the efficacy of DNA vaccination in induction of immune responses in HIV-1-infected human beings. METHODS: Nine symptom-free HIV-1-infected patients were immunised with DNA constructs encoding the nef, rev, or tat regulatory genes of HIV-1. The patients were selected for having no or low antibody reactivities to these antigens. HIV-1-specific cytotoxic T-lymphocytes (CTLs), precursor frequencies, and antigen-specific proliferative responses were measured before, during, and after three immunisations over 6 months. FINDINGS: Cellular immune reactivities against the HIV-1 regulatory proteins were absent or low before DNA immunisation. DNA vaccination induced detectable memory cells in all patients and specific cytotoxicity in eight patients. CTLs were MHC-class-I restricted and mainly of CD8+ origin. In three patients the cellular activity was transient, decreasing after an initial response. INTERPRETATION: DNA immunisation with HIV-1 genes can induce specific cellular responses in human beings with no apparent side-effects. It is theoretically possible that HIV-1-specific cytotoxic responses to regulatory proteins could lead to infected cells being eliminated before they have released new viral particles. However, it is possible that the patients we selected responded less than would non-selected or non-infected individuals. The small number of patients presented here does not allow generalisation of our findings.
机译:背景:DNA疫苗接种可在动物模型中产生针对HIV-1的免疫反应。我们旨在评估DNA疫苗接种在HIV-1感染人类中诱导免疫应答的功效。方法:用编码HIV-1 nef,rev或tat调控基因的DNA构建体对9例无症状的HIV-1感染患者进行免疫。选择对这些抗原没有或具有低抗体反应性的患者。在六个月内进行三次免疫接种之前,期间和之后,测量HIV-1特异性细胞毒性T淋巴细胞(CTL),前体频率和抗原特异性增殖反应。结果:在进行DNA免疫之前,没有针对HIV-1调节蛋白的细胞免疫反应性很低。 DNA疫苗接种可在所有患者中诱导出可检测的记忆细胞,并在八名患者中产生特异性细胞毒性。 CTL受MHC-I类限制,并且主要来自CD8 +。在三名患者中,细胞活性是短暂的,在初始反应后降低。解释:用HIV-1基因进行DNA免疫可以诱导人类产生特定的细胞反应,而没有明显的副作用。从理论上讲,HIV-1对调节蛋白的细胞毒性反应可能会导致感染的细胞在释放出新的病毒颗粒之前被清除。但是,我们选择的患者有可能比未选择或未感染的个体反应少。此处介绍的少数患者无法概括我们的发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号